Study to Investigate the Safety, Tolerability, and Pharmacokinetic Profile With Oral AB521 in Healthy Volunteers
Clinical trial NCT05117554 · COMPLETED
Trial details
- NCT number
- NCT05117554
- Sponsor
- Arcus Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-09
- Primary completion
- 2023-02-17
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.